drugset
drugset / Trial / NCT07252336

A Multicenter Study of CAR-T Cells in Primary Ph+All

NCT07252336 ↗

Phase 2 Recruiting 50 enrolled Zhejiang University Yake Biotechnology Ltd. · collab
NaSingle-groupOpen-labelTreatment

Summary

A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients With Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia

Timeline

Start
2025-11-30
Primary completion
2027-11-30
Completion
2028-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CD19 CAR-T cells Cell therapy 2e+06 cells/kg Intravenous

Indications

No indication recorded.